Class Switching in B Cells Lacking 3′ Immunoglobulin Heavy Chain Enhancers by Manis, John P. et al.
 
1421
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/98/10/1421/11 $2.00
Volume 188, Number 8, October 19, 1998 1421–1431
http://www.jem.org
 
Class Switching in B Cells Lacking 3
 
9
 
 Immunoglobulin
Heavy Chain Enhancers
 
By John P. Manis,
 
*
 
‡
 
 Nienke van der Stoep,
 
*
 
‡
 
 Ming Tian,
 
*
 
‡
 
 
Roger Ferrini,
 
*
 
‡§ 
 
Laurie Davidson,
 
*
 
‡
 
 Andrea Bottaro,
 
§
 
and Frederick W. Alt
 
*
 
‡§
 
i
 
From 
 
*
 
The Howard Hughes Medical Institute and 
 
‡
 
The Children’s Hospital, Boston, Massachusetts 
02115; and the
 
 §
 
Center for Blood Research and 
 
i
 
Department of Genetics, Harvard Medical School, 
Boston, Massachusetts 02115
 
Summary
 
The 40-kb region downstream of the most 3
 
9
 
 immunoglobulin (Ig) heavy chain constant re-
gion gene (C
 
a
 
) contains a series of transcriptional enhancers speculated to play a role in Ig
heavy chain class switch recombination (CSR). To elucidate the function of this putative CSR
regulatory region, we generated mice with germline mutations in which one or the other of
the two most 5
 
9
 
 enhancers in this cluster (respectively referred to as HS3a and HS1,2) were re-
placed either with a pgk-
 
neo
 
r
 
 cassette (referred to as HS3aN and HS1,2N mutations) or with a
 
loxP
 
 sequence (referred to as HS3a
 
D
 
 and HS1,2
 
D
 
, respectively). B cells homozygous for the
HS3aN or HS1,2N mutations had severe defects in CSR to several isotypes. The phenotypic
similarity of the two insertion mutations, both of which were 
 
cis
 
-acting, suggested that inhibi-
tion might result from
 
 
 
pgk-
 
neo
 
r
 
 cassette gene insertion rather than enhancer deletion. Accord-
ingly, CSR returned to normal in B cells homozygous for the HS3a
 
D
 
 or HS1,2
 
D
 
 mutations. In
addition, induced expression of the specifically targeted pgk-
 
neo
 
r
 
 genes was regulated similarly
to that of germline C
 
H
 
 genes. Our findings implicate a 3
 
9
 
 CSR regulatory locus that appears re-
markably similar in organization and function to the 
 
b
 
-globin gene 5
 
9
 
 LCR and which we
propose may regulate differential CSR via a promoter competition mechanism.
Key words: immunoglobulin genes • class switching • enhancers • gene-targeted mutation • 
transcription
 
I
 
mmunoglobulin (Ig) variable regions are encoded by
germ-line V, (D), and J gene segments that are assembled
 
during early B cell differentiation by V(D)J recombination
(for review see reference 1). The Ig heavy (H)
 
1
 
 chain locus
contains eight different constant region (C
 
H
 
) genes with the
organization: 5
 
9
 
V(D)J-C
 
m
 
-C
 
d
 
-
 
C
 
g
 
3-C
 
g
 
1-C
 
g
 
2b-C
 
g
 
2a-C
 
e
 
-
C
 
a
 
-3
 
9
 
. Differentiating B lymphocytes first produce H chains
in the context of an IgM surface receptor. During antigen-
driven B cell maturation, B cells can secrete specific antibody
with a different C
 
H
 
 region effector function by juxtaposing
the antigen-specific V(D)J gene to a different downstream
C
 
H
 
 gene via a recombination/deletion process termed class
switch recombination (CSR; for review see reference 2).
CSR occurs between tandem repetitive switch (S) region
sequences present 5
 
9
 
 of individual germline C
 
H
 
 genes.
CSR to particular C
 
H
 
 genes is directed by different com-
binations of activators and lymphokines (3–6). For exam-
ple, stimulation of B cells with bacterial LPS induces CSR
to the C
 
g
 
2b and C
 
g
 
3; whereas LPS plus IL-4 induces CSR
to C
 
g
 
1 and C
 
e
 
. Factors that modulate switching to particu-
lar C
 
H
 
 genes correspondingly modulate germline transcrip-
tion of those genes before CSR (7–13). Thus, LPS treat-
ment of splenic B cells induces germline C
 
g
 
2b and C
 
g
 
3
transcription; whereas LPS plus IL-4 treatment suppresses
germline C
 
g
 
2b and C
 
g
 
3 expression, and induces germline
C
 
g
 
1 and C
 
e
 
 gene transcription. All C
 
H
 
 gene transcripts ini-
tiate at an exon termed I that lies 5
 
9
 
 to each S region, pro-
ceed through the S region and C
 
H
 
 gene, and are processed
to yield noncoding transcripts with the I exon spliced to
the C
 
H
 
 exon. Gene-targeted mutational analyses of I region
exons/promoters have confirmed that germline C
 
H
 
 tran-
scription and/or transcripts play a direct role in CSR (14–
19). Therefore, control of CSR is directly related to ability
to control transcription of the various C
 
H
 
 genes.
Understanding of the mechanisms that regulate CSR
will require elucidation of both 
 
trans
 
- and 
 
cis
 
-acting ele-
 
1
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ments that modulate germline C
 
H
 
 transcription. In this
context, C
 
H
 
 gene promoters contain consensus sequences
that are responsive to specific lymphokines (reviewed by
Coffman et al. [20]). Yet, properly regulated expression of
germline C
 
H
 
 genes requires sequences beyond those of
their proximal promoters (21). In this regard, efficient CSR
from C
 
m
 
 to a downstream C
 
H
 
 gene requires the transcrip-
tional enhancer element (iE
 
m
 
) found in the J
 
H
 
/C
 
m
 
 intron
(22). However, the expression of switched transcripts or
translocated oncogenes on alleles in which iE
 
m
 
 is absent
suggested the presence of additional downstream positive
regulatory sequences (23–25).
The first candidate for such a downstream transcriptional
enhancer was the so-called 3
 
9
 
C
 
a
 
E or 3
 
9
 
EH (Fig. 1, 
 
A 
 
and
 
B
 
), which was identified 
 
z
 
15 kb 3
 
9
 
 of C
 
a
 
 based on ability
to enhance transcription specifically in B lineage cells (26–
28). Homozygous replacement of this element (also re-
ferred to as HS1,2, see below) with a pgk-
 
neo
 
r
 
 gene dis-
rupted CSR and germline transcription of a series of C
 
H
 
genes, including C
 
g
 
3 which lies 120 kb upstream (29). As-
suming that these effects were 
 
cis
 
-acting, one hypothesis to
explain this phenotype was that HS1,2 is critical for induc-
tion of germline C
 
H
 
 gene transcription and that its deletion
was the primary cause of the CSR phenotype (29, 30). A
second possibility is that insertion of the pgk-
 
neo
 
r
 
 gene cas-
sette in the 3
 
9
 
 IgH locus disrupts the normal regulation of
germline transcription/CSR by interfering with the activi-
ties of additional required regulatory elements (29).
The 40-kb region just downstream from C
 
a
 
 contains
four enhancer elements (that correspond to DNAase1 hy-
persensitive or HS sites): HS3a (or C
 
a
 
3
 
9
 
E), which lies 4 kb
3
 
9
 
 to the C
 
a
 
; HS1,2 (or 3
 
9
 
CaE), which lies 15 kb 39 to
Ca; HS3b, which lies 25 kb 39 to Ca; and HS4, which lies
z30 kb 39 to Ca (26–28, 31, 32). Like the HS1,2 se-
quence, HS3a (31) and HS3b (32) enhance reporter gene
expression in activated B cells and plasma cells. On the
other hand, HS4 is active throughout B cell development
(32, 33). HS3a, HS1,2, and HS3b appear to represent a unit
with HS3a and HS3b sharing high sequence homology,
but lying in inverted orientation in the chromosome (34,
35). Recent studies have shown these enhancer sequences
are conserved in man, consistent with an important regula-
tory function (36, 37).
Combinations of HS3b, HS1,2, and HS4 had synergistic
transcriptional enhancing effects when assayed in a trans-
genic mouse model, and were able to induce copy number
and position-independent reporter gene expression, sug-
gesting that these sequences have locus control region
(LCR) properties (32). In this regard, a similar set of HS
sites that lie upstream of the b-globin gene locus constitute
a b-globin LCR, that apparently is responsible for coordi-
nating expression of the various b-globin genes during de-
velopment (reviewed by Martin et al. [38]). Individual HS
sites within the b-globin LCR also have transcriptional en-
hancer activity and replacement of 2 of these individually
with an expressed selectable marker gene cassette resulted
in decreased b-globin expression across the locus (39–41),
an effect reminiscent of what was observed when HS1,2
was replaced with a neor gene (29). Yet “clean” deletion of
the b-globin HS sites had no major effect, indicating that
the effects of the pgk-neor gene insertion resulted from in-
terference with additional regulatory sequences (40, 41).
To elucidate the function of the putative 39 IgH regula-
tory region and assess the roles of specific enhancers, we
have generated mice with germline mutations in which a
pgk-neor cassette or a loxP site replaced either the HS3a or
the HS1,2 elements and then assayed the effects of these
mutations on the CSR process.
Materials and Methods
Vector Construction, Transfection, and Embryonic Stem Cell Screen-
ing. For the generation of HS1,2 mutant mice, a previously de-
scribed construct (29) was modified by deleting its existing pgk-
neor cassette and substituting a loxP flanked pgk-neor cassette in the
central Not1 site, by blunt end ligation (Fig. 1 D). The deletion
spanned from a Pst-1 site 1.8 kb 59 of the HS1,2 core element
(42) to an EcoR1 site 1.7 kb 39 of the element. This construct
was linearized using Pvu-1. A 600-bp EcoR1-Xba fragment 59 of
HS1,2 was used as a probe in Southern blotting.
The HS3a mutant embryonic stem (ES) cells were derived us-
ing pLNTK vector P3 (43), cloning the 3-kb H3 fragment con-
taining the alpha membrane exon in the Sal1 site and a 3.4-kb
Hind3-Xba fragment into the Xho site, and deleting the 2-kb
fragment that contains the previously described 900-bp enhancer
(31) HS3a (Fig. 1 C). This construct was linearized using Sal1. A
500-bp EcoR1-Hind3 fragment was used as a probe in Southern
blotting.
Approximately 20 mg of linearized construct DNA was elec-
troporated into 2 3 107 J1 or E14 ES cells (HS1,2 and HS3a tar-
getings, respectively) and homologous recombinants were se-
lected as previously described (44). One ES clone was injected
into C57Bl/6 blastocysts to generate germline chimeric mice,
each where a pgk-neor cassette inserted correctly into one allele of
either HS3a or HS1,2. Germline transmitting mice were then in-
terbred to produce either mice homozygous for the HS3aN or
HS1,2N mutation. Females homozygous for either mutation
were bred with males containing an EIIa-Cre transgene (43, 45)
to produce mice heterozygous for HS3aD or HS1,2D. Subse-
quent breeding of these mice yielded animals homozygous for
HS3aD or HS1,2D. To keep the strains in all mutant mice similar,
we bred mice with the HS3aN or HS1,2N (which were in a 129 3
C57BL/6 background) with FVB mice (the strain of the EIIa-Cre
Tg mice). Again mice were interbred to produce homozygous
mutants for HS3aN or HS1,2N.
Spleen Cell Cultures. Single-cell suspensions of spleen cells
were cultured at 5 3 105 cells/ml in RPMI medium supple-
mented with 10% FCS and 20 mg/ml LPS with or without 50
ng/ml of mouse recombinant IL-4 as previously described (18).
Cultures for IgG2a and IgA production were prepared as previ-
ously described (29). Cells were harvested for FACs, and superna-
tants assayed on days 4–5.
Flow Cytometry Analysis. Single-cell suspensions from spleens
were prepared as previously described (18). Cells from day 4 or 5
cultures were washed in PBS, 2% FCS and stained with various
antibodies conjugated with fluorescein (IgG1), phycoerythrin
(IgM), biotin (IgG2b, IgG3, IgE, IgG2ba/IgG2aa, IgG2aa), or Cy-
chrome (B220; PharMingen, San Diego, CA). Biotin conjugates
were revealed by phycoerythrin-streptavidin (PharMingen). The
cells were analyzed on a FACScaliburÒ (Becton Dickinson &1423 Manis et al.
Co., Sparks, MD) and analyzed using Cellquest software, and are
presented as dot plots after gating for live cells.
ELISA Assays. Supernatants from spleen cell cultures and
sera from normal B6/CBA mice or germline mutant mice were
analyzed for the presence of different immunoglobulin isotypes
by ELISA as described (18). Cultures were established in triplicate
for each assay. In total, three independent culture experiments
were performed for wild-type and the four different 39 IgH en-
hancer mutant mice. Mice ranged in age from 6 wk to 3 mo, and
culture supernatants were assayed after 5 d of stimulation.
Southern and Northern Blot Analyses. Genomic DNA was pre-
pared as previously described (46). RNA was prepared using the
TRIZOL reagent (GIBCO BRL, Gaithersburg, MD) as per the
instructions of the manufacturer. Southern and Northern blot
analyses were performed as described elsewhere (18). The mb-1
probe was generated from a full-length cDNA. The Pgk probe is
a 300-bp R1-H3 fragment, and the neo probe is a 500-bp R1-Pst
fragment. The Ig2b probe is a 500-bp H3-Xho fragment. The Ce
probe is a 2.5-kb Sac fragment.
PCR Amplification of Germline Transcripts. Total RNA was iso-
lated from 1 3 106 day 3 LPS/IL-4–stimulated splenocytes, using
the TRIZOL reagent (GIBCO BRL) as per the manufacturer’s
instructions. cDNA was generated using Superscript (GIBCO
BRL), again according to manufacturer’s instructions. For Ce, 1/
10 the total cDNA was amplified using a forward PCR primer
(these data are available from GenBank/EMBL/DDBJ under ac-
cession numbers 194466 and 194457) of 59-acggggtgtgattacctac-
ctgat-39, and a reverse primer of 59-gatattgttttcagtttcctg-39. 30 cy-
cles of 948C 3 1 min, 558C 3 30 s, and 728C 3 1 min were
performed in a Perkin Elmer 9600 thermal cycler (Perkin-Elmer
Corp., Norwalk, CT). The reaction was then directly digested
with 10 U of Sty 1 for 1 h, electrophoresed on a 3% agarose gel,
and directly visualized with EtBr staining.
The PCR amplification of germline transcripts was performed
as previously described, using 59-caagtggatctgaacaca-39 and 59-
ggctccatagttccatt-39, for g3 forward and reverse, respectively. For
germline e the primers used are 59-actagagattcacaacg-39 and 59-
agcgatgaatggagtagc-39, for forward and reverse, respectively. Both
reactions were carried out as in Zelazowski et al. (47) for 28 cy-
cles. mb-1 primers as described in Li et al. (48) were used in a re-
action for 18 cycles. The products were run on a 2% agarose gel,
transferred to a nylon membrane, and hybridized with the probes
described above.
Generation of Chimeric Mutant Mice of a Randomly Integrated
HS1,2 Targeting Construct. Four independent ES cell lines that
contained randomly inserted HS1,2 targeting constructs (HS1,-
2RAN) and two HS1,2N/1 ES subclones were injected into
blastocysts from the RAG-2–deficient mice and transplanted into
foster mothers (B6/CBA) as described (49). Chimeric mice with
lymphocytes derived from either the randomly or specifically tar-
geted HS1,2N constructs were analyzed in splenic cultures as de-
scribed above.
Results
Generation of Mice with Targeted Replacements or Deletions of
HS3a or HS1,2. ES cells were transfected separately with
constructs that replace either the entire HS3a or HS1,2
with a loxP-flanked pgk-neor gene cassette (Fig. 1, B–D;
mutations termed HS3aN and HS1,2N, respectively). ES
clones with appropriate targetings of the endogenous loci
were used to introduce each of the mutations into the mu-
rine germline. Mice homozygous for either replacement
mutation appeared normal and had B cell numbers in pe-
ripheral lymphoid organs that were similar to those of
wild-type controls (data not shown). To generate mice
with a “clean” deletion of each of the respective enhancer
elements, the introduced loxP-flanked pgk-neor gene was
deleted by breeding the mice containing the HS3aN or
HS1,2N mutations with a mouse that expresses an EIIa-
Cre recombinase transgene at a very early developmental
stage, and which permits generation of progeny that have
deleted the neor gene in the germline (45). From the prog-
eny of this cross, we identified individuals in which the
pgk-neor gene was deleted, resulting in replacement of the
HS3a or HS1,2 sites with only a loxP sequence. Mice ho-
mozygous for these deletion mutations (termed HS3aD and
HS1,2D, respectively; Fig. 1) again appeared normal, and
contained B cell numbers comparable to those of wild-type
mice (data not shown).
Deficient Serum Isotype Levels in Mice Homozygous for the
HS3aN or HS1,2N Mutations. Previously, homozygous re-
placement of HS1,2 with a pgk-neor cassette in ES cells
followed by assay via the RAG-2–deficient blastocyst com-
plementation system showed that this mutation led to chi-
meric mice with markedly decreased serum levels of IgG3
and IgG2a, but relatively normal levels of other isotypes in-
cluding IgM (29). To assay the effects of the germline re-
placement mutations, we quantified serum Ig levels in mice
homozygous for the HS1,2N and HS3aN mutations (re-
ferred to as HS1,2N/N and HS3aN/N mice, respectively).
The serum IgM levels in both mutant lines were similar to
those of wild-type control mice (Fig. 2). Levels of IgG1,
IgG2b, and IgA also were substantial but there was no de-
tectable IgG3 or IgG2a (Fig. 2). IgE levels were not deter-
mined as they were below the detection level of our assay
even in normal mice (not shown). Thus, replacement of ei-
ther HS1,2 or HS3a with a pgk-neor cassette resulted in es-
sentially identical defects in serum Ig expression, even
though the sites of the replacement mutations were sepa-
rated by 12 kb within the downstream IgH region. This
finding indicates that either HS3a and HS1,2 are indepen-
dently essential for promoting CSR to these isotypes or
that the neor gene interferes with additional elements when
placed at either site.
Severe Class-switch Defects In Vitro in HS3aN/N and
HS1,2N/N Splenic B Cells. Our previous studies showed
that splenic B cells generated from ES cells homozygous for
a HS1,2-pgk-neor gene via replacement mutation by RAG-
2–deficient blastocyst complementation had severe defects
in CSR and in transcription of the Cg3, Cg2b, Cg2a, and
Ce genes (29). To determine whether HS1,2N/N or
HS3aN/N splenic B cells were similarly affected, we cul-
tured both types of mutant B cells for 4 or 5 d in the pres-
ence of either LPS, LPS 1 IL-4, LPS 1 IFN-g, or LPS 1
TGF-b, agents that collectively are known to induce class
switching to Cg3 and Cg2b, Cg1 and Ce, or Cg2a and
Ca, respectively. Both mutant cell types proliferated simi-
larly to normal cells after the various treatments (data not
shown). Supernatant antibody levels in the cultures after 51424 39 Heavy Chain Enhancers and Class Switching
days of treatment were measured by ELISA using isotype
specific antibodies. After appropriate stimulation, secreted
levels of IgM were similar in cultures of HS1,2N/N,
HS3aN/N and wild-type B cells, while the levels of IgG1
and IgA secreted by the mutant cells were significant but
generally lower than those of normal control B cells (Fig.
3). However, IgG3, IgG2b, IgG2a, or IgE were not detect-
able in the supernatants of the HS1,2N/N and HS3aN/N
B cells, which indicated a reduction of 100-fold or more
from wild-type levels (Fig. 3). Surface stains of day 4 stimu-
lated cells confirmed a substantial inhibition of switching to
IgG3, IgG2b, IgG2a, and IgE, accompanied by an appar-
ently slight inhibition of switching to IgG1 and relatively
normal switching to IgA (data not shown).
To analyze the consequences of replacing HS3a with
pgk-neor cassette on expression of germline CH transcripts,
we assayed total RNA from LPS and LPS plus IL-4–stimu-
lated HS1,2N/N and HS3aN/N B cells for hybridization
to an Ig2b-region specific probe (Fig. 4 A). These studies
demonstrated major inhibition in the expression of germ-
line Ig2b transcripts in LPS cultures of the N/N cells (Fig.
4 A). Additional assays revealed a similar lack of germline
Figure 1. Targeted mutations
of the HS3a and HS1,2 enhanc-
ers. (A) Partial map of the 39 IgH
locus representing the arrange-
ment of the heavy chain constant
region genes and enhancers de-
picted by filled boxes or ovals.
The open circle labeled iEm rep-
resents the intronic heavy chain
enhancer (map not drawn to
scale). (B) The open box repre-
sents the Ca membrane coding
region. The open ellipses repre-
sent various enhancer elements,
HS3a (CaEH), HS1,2 (39EH),
HS3b, and HS4. (C) The target-
ing for the HS3a was detected
using the depicted H3-R1 500-
bp probe, yielding a genomic
band of 4.7 kb by EcoR1 digest,
and a 4.3-kb band after homolo-
gous recombination with a lox
flanked pgk-neor gene. Upon
Cre-mediated deletion of the
pgk-neor cassette a 10.6-kb band
is detected. (D) HS1,2 was tar-
geted using the depicted con-
struct, where a 600-bp EcoR1-
Xba fragment detects a 11.7-kb
germline band and a 10.1-kb tar-
geted band. Upon Cre-medi-
ated deletion of the selectable
marker, the mutated band is de-
tected at 6.8 kb. Restriction en-
zymes: B, BamH1; R1, EcoR1;
H3, Hind3; Xba, Xba 1.
Figure 2. Selective serum im-
munodeficiency in HS1,2N/N
and HS3aN/N mice but not in
HS3aD/D or HS1,2D/D mice.
Concentrations of specific im-
munoglobulin isotypes in sera
from HS1,2N/N (open squares),
HS3aN/N (open circles), HS3aD/D
(closed circles), HS1,2D/D ( closed
squares) mice with their wt (closed
triangles) littermates are shown. N
represents the N/N mice, D rep-
resents the D/D mice, and WT
indicates wild-type littermate
controls. All isotypes except IgE
were quantified by ELISA.1425 Manis et al.
transcripts from other CH genes (e.g., Cg3 and Ce) after
appropriate in vitro stimulation of HS1,2N/N and
HS3aN/N B cells (Fig. 4 C). Together, these findings show
that homozygous replacement of either HS3a or HS1,2
with a pgk-neor gene results in an essentially identical defect
of CSR to IgG3, IgG2b, IgG2a, and IgE after in vitro stim-
ulation, and that this defect corresponds in turn to a block
in the induction of the respective germline CH transcripts.
Again, these findings could be consistent with either a re-
quired function for both HS3a and HS1,2 in the CSR pro-
cess or an effect of the inserted pgk-neor gene on an addi-
tional regulatory element.
Inhibition of CSR by the pgk-neor Replacement Mutations
Occurs in a Cis-acting Fashion. The defect in CSR ob-
served in either the HS3aN/N or HS1,2N/N B cells could
occur via disruption of a critical cis-acting control element
for CSR (29). To directly assay for this, we generated mice
harboring one allele with a pgk-neor replaced enhancer ele-
ment, and one wild-type allele. The ES cells used in our
targetings were derived from the 129 mouse strain which
carries the IgHa haplotype. The mutant mice were bred
with C57Bl/6 mice that carry the IgHb haplotype, allowing
the generation of heterozygous mutant progeny that harbor
an IgHa allele with the neor mutation and a wild-type IgHb
allele. The haplotypic differences between the IgHa and the
IgHb alleles can be distinguished at the DNA level (based
on nucleotide sequence differences manifested as unique
restriction endonuclease sites), as well as at the protein level
by antibodies specific for the IgHa and IgHb polymor-
phisms.
Splenocytes from the wild-type, HS3aN/1, and
HS1,2N/1 mutant mice were stimulated in vitro with ei-
ther LPS or LPS1IL-4, and activated B cells were collected
for analysis after 4 d of stimulation. LPS-stimulated cells
were doubly stained with a biotin-conjugated antibody that
recognizes the IgHa type allele of IgG2b and IgG2a isotypes
(IgG2ba and IgG2aa, respectively), and one that recognizes
total IgG2b (both IgHa and IgHb allotypes). Wild-type B
cells heterozygous for the normal IgHa and IgHb alleles had
similar numbers of B cells that stained for either surface
IgG2ba or IgG2bb positive cells (Fig. 5 A). However, mice
heterozygous for either mutant IgHa allele and the wild-
type IgHb allele expressed only surface IgG2bb positive B
cells indicating a cis-acting defect of the mutations on class
switching to IgG2b (Fig. 5 A, labeled HS3aNa/1b or
HS1,2Na/1b).
To assay for allele-specific transcripts of the Ce region,
we employed PCR for specific amplification of all tran-
scripts through the Ce constant region. The IgEb haplotype
contains an additional Sty-1 restriction site in the 453 base
pairs spanning the first 2 Ce constant region exons, as com-
pared with the IgEa haplotype. Therefore, RT-PCR prod-
ucts of transcripts arising from the two alleles can be differ-
entiated based on the size of fragments generated after
digestion with Sty-1. LPS plus IL-4–stimulated B cells from
mice heterozygous for the wild-type IgHa and IgHb alleles
generated an approximately equal ratio of Ce-containing
transcripts from the two alleles (Fig. 5 B). In contrast,
almost all detectable Ce-transcripts in LPS plus IL-4–stim-
ulated B cells from mice heterozygous for either the
HS1,2N or HS3aN IgHa allele and the wild-type IgHb al-
lele were generated from the wild-type (IgHb) allele (Fig. 5 B).
In summary, both pgk-neor replacement of either HS3a
or HS1,2 regions resulted in a cis-acting defect in CSR, as
measured both by transcripts and surface protein expres-
sion, indicating that the effects of the neor gene replacement
mutations disrupted a cis-acting control element.
Normal Class Switch Recombination and Germline CH Tran-
scription in HS3aD/D or HS1,2D/D B Cells. To further elu-
cidate the mechanism by which the HS3aN and HS1,2N
insertion mutations inhibited CSR, we assayed for class
switching by B cells of HS3aD/D and HS1,2D/D mice.
Splenic B cells from both homozygous deletion mutant
mice expressed a wild-type distribution of surface IgM and
IgD (data not shown). Likewise, the levels of serum IgM
and all other assayed downstream isotypes were similar to
those of the wild-type control animals (Fig. 2). Thus, spe-
cific deletion of either the HS3a or HS1,2 enhancers had
no readily measurable effect on serum Ig levels. Moreover,
after LPS or LPS plus lymphokine stimulation of HS3aD/D
and HS1,2D/D splenic B cells, we observed induction of
surface and secreted Ig isotypes that were generally similar
Figure 3.  In vitro defect of
class switching in HS1,2N/N
and HS3aN/N mice but not in
HS3aD/D or HS1,2D/D mice.
Splenic B cells from the indi-
cated mice were cultured for 5 d
in the presence of LPS (IgM,
IgG3, and IgG2b), or LPS 1 IL4
(IgE and IgG1), or LPS 1 IFN-g
for IgG2a, or LPS 1 TGF-b (for
IgA). Culture supernatants were
analyzed by ELISA to quantify
secreted immunoglobulin levels.
N represents the N/N mice, D
represents the D/D mice, and
WT indicates wild-type litter-
mate controls.1426 39 Heavy Chain Enhancers and Class Switching
in level to those of wild-type control mice (Fig. 3 and data
not shown). Although there were potentially small effects
on switching to certain isotypes (e.g., IgG2b and IgE; Fig.
3), these are difficult to assess given the inherent variations
in these population assays. Overall, our results indicate that
neither the HS1,2 nor the HS3a enhancers are required for
LPS and lymphokine-stimulated CSR and expression of
IgH isotypes.
To test for the effects of specific deletions of HS3a or
HS1,2 on expression of germline CH transcripts, we assayed
RNA prepared from the LPS or LPS plus IL-4–treated cul-
tures of HS3aD/D and HS1,2D/D B cells for hybridization
to an Ig2b-specific probe (Fig. 4 B). We readily observed
the induction of Ig2b-containing germline transcripts upon
LPS activation of these cells, in striking contrast to the lack
of induction observed in LPS-activated cultures of HS3aN/N
and HS1,2N/N B cells. (compare Fig. 4, A with B). PCR
amplification of germline transcripts containing Ig3 or Ie
yielded similar findings (Fig. 4 C). We do note that the ex-
tent of induction appeared to be less in the HS1,2 D/D B
cells than in wt cells (Fig. 4 B and data not shown). Al-
though the potential for more modest effects on expression
will need to be examined in further detail, we conclude
from these studies that neither the HS3a nor the HS1,2 en-
hancers are absolutely needed for substantial induction of
germline CH gene transcription or the CSR process that
follows.
The pgk-neor Gene Is LPS Inducible When Inserted into the
39 IgH Locus. Insertion of the pgk-neor cassette into either
the HS3a or HS1,2 location in the 39 IgH locus inhibits
germline transcription of CH genes up to 120 kb away (Fig.
4). To further analyze the potential mechanisms involved,
we assayed for expression of the pgk-neor cassette when it
Figure 4. Marked inhibition of inducible germline Cg2b transcription in
HS12N/N and HS3aN/N but not HS3aD/D or HS1,2D/D B cells. Splenic
B cells from wt, HS3aN/N and HS12N/N mice (A), or HS3aD/D, and
HS1,2D/D (B). B Cells were cultured for 5 d with LPS or LPS plus IL-4.
Total RNA was isolated on days 0 (D.0) and 3 (D.3) and separated on a
denaturing 1% agarose gel and assayed for expression of Ig2b and mb-1
hybridizing transcripts. The Ig2b probe detects both the membrane
(m-Ig2b) and secreted (s-Ig2b) forms of transcript as indicated. RNA from
wild-type controls was obtained from cultures derived from littermates of
the mutant mice. (C) RT-PCR for g3 or e germline transcripts was per-
formed on the above samples, as outlined in the methods. Fivefold dilu-
tions of cDNA were diluted into mouse genomic DNA to keep a con-
stant amount of 100 ng total DNA per reaction. Probes internal to the
PCR primers for Ig3 or Ie were used for hybridization. Wild-type con-
trols are indicated with w and mutant N/N and D/D mice are indicated,
respectively, with N and D.
Figure 5. The HS1,2N and HS3aN mutations disrupt class switching
in cis. Splenocytes from mice with either the HS3a or the HS1,2 elements
replaced by a pgk-neor cassette on their IgHa haplotype allele, and a wild-
type IgHb haplotype allele, were analyzed. (A) Day 4 splenocyte cultures
were stained with an antibody detecting both IgG2ba or IgG2bb, and one
which detects IgG2ba and IgG2aa. LPS-stimulated B cells from mutant
mice reveal cells staining only for IgG2bb. (B) RT-PCR of transcripts
through Ce, digested with Sty 1 reveal a 200-bp fragment generated from
the IgHa allele, and a 150-bp fragment from the IgHb allele.1427 Manis et al.
was inserted in place of the HS1,2 sequences. For this pur-
pose, we assayed total splenocyte RNA from HS1,2N/1
mice for hybridization to a neor gene-specific probe. Ex-
pression of endogenous pgk sequences (which are ubiqui-
tously expressed) and the Mb-1 sequence (which is B cell
specific) was measured as a control. RNA from thymus and
from nonlymphoid tissues had very low levels of pgk-neor
transcripts, from the specifically inserted pgk-neor gene (data
not shown). However, HS1,2N spleen RNA contained
significant levels of neor transcripts (Fig. 6, lanes 3 and 5).
To determine if these neor transcripts were expressed and
inducible in B lymphocytes, we assayed RNA from cul-
tures of HS1,2N/1 spleen cells treated for 4 or 5 d with
LPS. These RNA preparations showed a significantly
higher level of neor gene transcripts (representing as much as
a fivefold induction; Fig. 6; compare lanes 3 and 5 with
lanes 9, 11, 14, and 16). Furthermore, we also observed
similarly elevated expression levels of the pgk-neor gene in
LPS-treated HS3aN/N splenic B cells (data not shown),
indicating that such induction occurs with respect to neor
genes targeted at two independent sites in the 39 IgH locus.
These findings suggested that the pgk-neor sequences in-
serted into the 39 IgH region are specifically expressed and
LPS-inducible in B cells. As a control for this experiment,
we used ES cell lines that contained randomly inserted
HS1,2 targeting constructs to generate splenic B cell popu-
lations by the RAG-2–deficient blastocyst complementa-
tion method (49). Spleen cells from these chimeric mice
were then assayed for neor and control gene transcription
before and after 5 d of culture in LPS. These cells prolifer-
ated and underwent class switching to IgG3 and IgG2b in a
manner similar to that of normal splenic B cells. However,
none of four independent populations of spleen cells with
random integrations of the HS1,2 targeting construct ex-
pressed levels of the pgk-neor gene above the very low lev-
els found in thymus or non-lymphoid tissues, either before
or after LPS treatment (Fig. 6, compare lanes 1, 2, and 4
with lanes 7, 8, 10 and 12, 13, 15).
Together, these data indicate that specific targeting of
the pgk-neor gene into the 39 IgH locus leads to its upregu-
lated expression in total splenic B cells and that this expres-
sion level is further augmented in LPS-stimulated B cell
populations.
Discussion
The 39 IgH Regulatory Region. The 40-kb region di-
rectly 39 of the IgH locus contains four known transcrip-
tional enhancer sequences, including HS3a, HS1,2, HS3b,
and HS4 (reviewed by Birshtein[42]) and is referred to as
the 39 IgH regulatory region. Cell transfection and trans-
genic studies indicated that the individual enhancers are
active in stimulated or terminally differentiated B cells,
suggesting they are involved in controlling late B cell dif-
ferentiation events such as CSR and high level IgH gene
expression (26, 30, 32, 50). However, until now, there has
been no direct examination of the potential role of any of
these elements during normal B cell development. Al-
though we previously demonstrated that replacement of
the HS1,2 enhancer with a pgk-neor cassette disrupted CSR
to multiple CH genes, the mechanism was not clear. Thus,
the block in CSR could have resulted from the deletion of
the HS1,2 enhancer, an inhibitory effect of the inserted
pgk-neor cassette on other elements, or both (29). Further-
more, the effects of the previous mutation could have re-
sulted from disrupting expression of a gene encoding a
trans-acting factor necessary for CSR (29). Our current
work clearly resolves these possibilities by showing that
neither HS3a nor HS1,2 are necessary for CSR or IgH
gene expression; whereas replacement of either with a pgk-
neor cassette interferes with CSR and germline transcription
of distant, cis-linked CH genes.
HS3a and HS1,2 Are Not Required for CSR or IgH Expres-
sion. HS1,2 was identified as a strong transcriptional en-
hancer that is active specifically in stimulated B cells and
plasma cells (26, 28). Previous studies demonstrated that
HS1,2 increased expression of linked transgenes and ren-
dered them LPS-inducible in B lineage cells (50, 51).
HS1,2 also contains numerous transcription factor binding
sites (52–55), further implicating it in transcriptional regu-
lation or related processes. HS3a, which lies 12 kb up-
stream of HS1,2 and immediately downstream of the Ca
gene, was similarly defined based on ability to enhance re-
porter gene expression specifically in late-stage B lineage
cell lines (31). This activity, combined with the finding that
HS3a also contains numerous factor-binding motifs, again
led to speculation about its potential roles in Ig HC gene
Figure 6. LPS-inducible neor gene expression from HS1,2N. Total
RNA samples isolated from spleen cells of either unstimulated or day 4 or
5 of LPS activation, and were separated on a denaturing formaldehyde
containing 1% agarose gel. Respectively, neor-, pgk-, and mb-1-RNA
transcripts were detected with specific probes as mentioned in experimen-
tal procedures and are indicated with an arrow. Lanes 1, 2, and 4 contain
RNA from unstimulated splenocytes that harbor a randomly integrated
HS12 pgk-neor targeting construct (HS12RAN) and are derived from ES
cell clones R12.3, R12.11 and R12.1, respectively. Lanes 7, 8, and 10,
contain RNA samples of ES-derived splenocytes (again clones R12.3,
R12.11 and R12.1) after 4 d of LPS stimulation, and lanes 12, 13, and 15
contain RNA samples of the same spleen cells after 5 d of LPS stimula-
tion. Lanes 3 and 5 contain RNA samples derived from unstimulated
spleen cells that harbor a targeted replacement of the HS12 pgk-neor tar-
geting construct. Lanes 9 and 11 contain RNA samples of the same spleen
cells after 4 d of LPS stimulation and lanes 14 and 16 contain RNA sam-
ples of the same spleen cells after 5 d of LPS stimulation. Lane 6 contains
RNA from unstimulated RAG-2–deficient spleen cells.1428 39 Heavy Chain Enhancers and Class Switching
expression or CSR (31). Our current studies are consistent
with the possibility that these enhancers, in particular
HS1,2, may have some role in influencing expression (Fig.
4). However, our finding that neither HS1,2 nor HS3a is
essential for V(D)J recombination, substantial expression of
germline CH transcripts, or IgH CSR and IgH expression is
surprising and necessitates consideration of other potential
functions for these elements. One possibility is in the so-
matic hypermutation process as 39 IgH region sequences
have been implicated by the finding of an increased occur-
rence of mutations in VHDJH transgenes recombined into
the IgH locus (56). The availability of mice containing germ-
line deletions of the individual 39 IgH enhancers will facili-
tate searches for more specific functions.
The lack of major effect of the HS3a or HS1,2 deletions
on measured processes might result from redundancy.
HS3a and/or HS1,2 share potential transcription factor
binding sites with HS3b and/or HS4 (36). Therefore, these
enhancers may have overlapping or redundant functions,
which could obviate major effects of the deletion of a sin-
gle element. In this context, disruption of the NF-kB p50
gene led to a phenotype reminiscent of the homozygous
HS1,2N/N or HS3aN/N phenotype, with impaired CSR
to an overlapping set of CH genes (57). As there are NF-
kB–binding sites in both the HS1,2 and HS4 enhancers
(58), it is possible that the NF-kB KO phenotype could re-
sult, at least in part, by interfering with the function of both
enhancers. Enhancer redundancy is found in the Igk locus,
where the intronic and 39 enhancers appear to have over-
lapping functions with respect to Igk gene rearrangement
and expression (43, 59). For some processes, the intronic
Em also may work in conjunction with 39 IgH sequences,
as expression of rearranged V(D)J sequences in iEm deleted
cell lines was suppressed upon replacement of HS1,2 with a
pgk-neor gene (30).
Our studies also demonstrate that expression of the Cg1
and Ca genes are less affected in vitro or in vivo even with
respect to the HS1,2N or HS3aN mutations, suggesting
that expression of these genes may be positively influenced
by control elements not influenced by the 39 IgH regula-
tory locus (29). Likewise, the finding that IgG2b levels are
suppressed with respect to in vitro LPS stimulation of
HS3aN/N  and HS1,2N/N B cells but are relatively normal
in vivo in the corresponding mice, supports the notion that
Cg2b can be activated in vivo by a novel pathway which is
independent of the 39 IgH regulatory region. The availabil-
ity of the germline mutant mice will facilitate the search for
such novel activating pathways and elements.
Similarities between the 39 IgH Regulatory Region and the
b-Globin 59LCR. The 39 IgH regulatory region is quite
reminiscent in organization to the LCR region 59 of the b
globin locus which similarly contains four erythroid-spe-
cific HS sites that individually harbor distinct transcrip-
tional enhancer activity (60). The b-globin LCR confers
tissue-specific, high level, position-independent expression
to cis-linked genes (61, 62), enhances transcription as far as
70 kb away, and influences chromatin structure and timing
of replication over .200 kb (63, 64). Similarly, the com-
bined HS1,2, HS3b, and HS4 sequences induced copy
number and position independence to transfected con-
structs, suggesting the 39 IgH region also may function as
an LCR (32). In another striking parallel to our current
findings, replacement of either the HS3 or HS2 enhancers
of the b-globin LCR with an expressed selectable marker
gene resulted in a severe block in the expression of the
linked b-globin locus; but, in both cases, b-globin locus
gene expression was substantially restored upon removal of
the selectable marker gene (40, 41). Heterozygous deletion
of the complete b-globin LCR in human cells of a thallas-
semia carrier eliminated b-globin gene expression in cis,
implicating its essential role in b-globin expression and
suggesting that the individual enhancer elements are redun-
dant (65). By analogy, more significant effects on CSR or
expression may occur upon simultaneous deletion of multi-
ple 39 enhancer elements (66). As insertion of the pgk-neor
cassette into both the 39 IgH HS3a and HS1,2 locations
blocks CSR to the same upstream genes and, in both cases
renders the inserted pgk-neor cassette LPS inducible, it
seems likely that major distal elements necessary for LPS in-
duction of germline CH transcription still lie downstream of
HS1,2, with HS3b and HS4 being prime candidates.
In addition to the 39 IgH locus and the b-globin locus,
inhibition of expression due to an inserted pgk-neor cassette
has been observed in several other loci (41, 43, 59, 67–70).
Although the effects of the inserted pgk-neor gene in differ-
ent loci may not necessarily occur via a single mechanism, a
common theme is the potential of complex, long-range
mechanisms that have evolved to control expression of de-
velopmentally regulated multi-gene loci. The effect of the
pgk-neor gene insertion in the b-globin LCR or the 39 IgH
region could be via the inhibition of the neighboring en-
hancer elements (38, 40, 41); for example, the HS1,2 re-
placement might inhibit transcription factors binding to the
HS3a, HS3b, or HS4 elements, and thereby inhibit all
three enhancer elements. However, a more likely scenario
is that the pgk-neor gene insertion results in interference
with long-range transcriptional control elements involved
directly with promoter–LCR interactions (71, 72) or long-
range effects on chromatin structure that modulate distal
promoter function (73). Recent studies of a transgenic
b-globin locus showed that a second b-globin gene com-
peted more efficiently with other genes to which it was
LCR-proximal (74), supporting the looping model of
LCR function in which one gene interacts with the LCR
at a time (75).
Additional insight into the potential mechanisms by
which the 39 IgH regulatory locus may modulate germline
CH transcription and/or CSR comes from recent studies of
lymphocytes in which the Ce or the Ig2b exons were re-
placed with a pgk-neor gene; class switching to CH genes
upstream, but not downstream of the pgk-neor insertion
was inhibited, again with the exception of switching to
IgG1 (Seidl, K., H. Oettgen, and F. Alt, manuscript in
preparation). On the other hand, other recent studies of B
cells in which the intronic Em element was replaced with a
pgk-neor cassette showed that the inserted pgk-neor cassette1429 Manis et al.
maintained CSR to downstream CH genes at relatively
normal levels even in the absence of Em (76). In this case,
the expressed pgk-neor cassette may have provided the nec-
essary transcriptional functions to promote CSR at the Sm
region whereas downstream germline transcription units
were unaffected by this 59 insertion. Together, all of these
studies are consistent with the notion that the pgk-neor in-
sertions inhibit CSR in a polarized fashion, primarily af-
fecting germline transcription units 59 to the insertion site.
In this regard, the b-globin LCR has been speculated to
regulate differential b-globin locus gene expression via a
promoter competition mechanism (71, 77). The 39 IgH
regulatory region might employ a similar mechanism to
regulate differential expression of CH genes dependent on
this region (29). Whatever the absolute mechanism, the
many similarities between the overall organization of the
b-globin LCR and the 39 IgH region suggest that these
two loci have evolved similar strategies to regulate differen-
tial gene expression.
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